Trasplante pulmonar en pacientes con fibrosis pulmonar: experiencia del Instituto Nacional del Tórax

Sepúlveda L, Claudia; Leiva V, Víctor; Linacre S, Virginia; Salinas F, Mauricio; Undurraga M, Pedro; López R, Jaqueline; Briceño V, Catalina; Gajardo Z, Francesca; Donoso G, Erika; Melo T, Joel.
Rev. chil. enferm. respir ; 35(1): 15-21, mar. 2019. tab, graf
Artículo en Español | LILACS | ID: biblio-1003642

Documentos relacionados

  1. Establishment of a risk prediction model for prolonged mechanical ventilation after lung transplantation: a retrospective cohort study.
  2. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort.
  3. Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study.
  4. Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis.
  5. Lung Transplant Type and Donor Age in Idiopathic Pulmonary Fibrosis: A Single Center Study.
  6. Ready and Waiting: Where Early-Stage Idiopathic Pulmonary Fibrosis Fibroblasts Are Primed to Be Activated.
  7. Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort.
  8. Association between weight loss and mortality in idiopathic pulmonary fibrosis.
  9. Pre-transplant anti-fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti-fibrotics?
  10. Medical Therapy in Idiopathic Pulmonary Fibrosis.